DK1809318T3 - Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet - Google Patents

Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet

Info

Publication number
DK1809318T3
DK1809318T3 DK05825013.5T DK05825013T DK1809318T3 DK 1809318 T3 DK1809318 T3 DK 1809318T3 DK 05825013 T DK05825013 T DK 05825013T DK 1809318 T3 DK1809318 T3 DK 1809318T3
Authority
DK
Denmark
Prior art keywords
short
treatment
thickness
syndrome patients
term syndrome
Prior art date
Application number
DK05825013.5T
Other languages
English (en)
Inventor
Elizabeth L Sanguinetti
Thomas B Marriott
Jennifer Lopansri
Consuelo Maria Blosch
Original Assignee
Nps Pharma Inc
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36319726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1809318(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nps Pharma Inc, Nycomed Gmbh filed Critical Nps Pharma Inc
Application granted granted Critical
Publication of DK1809318T3 publication Critical patent/DK1809318T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
    • A61B5/4222—Evaluating particular parts, e.g. particular organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
DK05825013.5T 2004-11-01 2005-11-01 Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet DK1809318T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62323304P 2004-11-01 2004-11-01
PCT/US2005/039222 WO2006050244A2 (en) 2004-11-01 2005-11-01 Treatment of short bowel syndrome patients with colon-in-continuity

Publications (1)

Publication Number Publication Date
DK1809318T3 true DK1809318T3 (da) 2013-09-08

Family

ID=36319726

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05825013.5T DK1809318T3 (da) 2004-11-01 2005-11-01 Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet

Country Status (8)

Country Link
US (70) US7847061B2 (da)
EP (1) EP1809318B1 (da)
JP (1) JP5197012B2 (da)
CA (1) CA2585482C (da)
DK (1) DK1809318T3 (da)
ES (1) ES2427150T3 (da)
HK (1) HK1107026A1 (da)
WO (1) WO2006050244A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184201B1 (en) 1995-04-14 2001-02-06 Nps Allelix Corp. Intestinotrophic glucagon-like peptide-2 analogs
US5834428A (en) * 1995-04-14 1998-11-10 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
DK1809318T3 (da) * 2004-11-01 2013-09-08 Nps Pharma Inc Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet
SI1877435T2 (sl) * 2005-05-04 2021-05-31 Zealand Pharma A/S Analogi glukagonu podobnega peptida-2(GLP-2)
NZ576260A (en) 2006-11-08 2012-04-27 Zealand Pharma As GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES comprising one of more substitutions as compared to h[Gly2]GLP-2
JP2013526535A (ja) * 2010-05-11 2013-06-24 エヌピーエス ファーマシューティカルズ インコーポレイテッド 腎機能障害または肝機能障害の治療または予防のための方法
WO2013164484A1 (en) 2012-05-03 2013-11-07 Zealand Pharma A/S Glucagon-like-peptide-2 (glp-2) analogues
US20170063005A1 (en) * 2015-08-27 2017-03-02 Tyco Electronics Corporation Array connector and method of manufacturing the same
TWI591177B (zh) 2016-10-27 2017-07-11 中化合成生技股份有限公司 一種胰高血糖素胜肽－２（ｇｌｐ－２）類似物的製備方法
KR102502040B1 (ko) 2016-12-09 2023-02-24 질랜드 파마 에이/에스 아실화 glp-1/glp-2 이중 효능제
WO2018142363A1 (en) * 2017-02-06 2018-08-09 Orbicular Pharmaceutical Technologies Private Limited Ready to use compositions of glp-2 analogues through self-administrable devices
EP3638291B1 (en) * 2017-06-16 2021-08-18 Zealand Pharma A/S Dosage regimes for the administration of glucagon-like-peptide-2 (glp-2) analogues
US10105588B1 (en) 2017-09-26 2018-10-23 Chasen Massey Snowboard binding with adjustment memory
CN111629745A (zh) * 2017-11-06 2020-09-04 夏尔-Nps医药品有限公司 用于在手术前、期间或之后投与的glp-2类似物和肽体(peptibodies)
EP3844500A4 (en) * 2018-08-27 2022-05-11 NantBio, Inc. RP182 COMPOSITIONS AND METHODS
KR20210126088A (ko) 2019-02-11 2021-10-19 옵코 바이오로직스 리미티드 지속성 glp-2 유사체
CN116157413A (zh) 2020-06-09 2023-05-23 维克蒂生物股份有限公司 阿普拉鲁肽的制造、配制和给药

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789379A (en) 1995-04-14 1998-08-04 Allelix Biopharmaceutical Inc. Glucagon-like peptide-2 analogs
US6184201B1 (en) * 1995-04-14 2001-02-06 Nps Allelix Corp. Intestinotrophic glucagon-like peptide-2 analogs
AU5882196A (en) 1995-06-06 1996-12-24 Kimberly-Clark Worldwide, Inc. Microporous film containing a microbial adsorbent
ES2351661T3 (es) 1996-04-12 2011-02-09 1149336 Ontario Inc. Péptido-2 análogo al glucagón.
EG21623A (en) 1996-04-16 2001-12-31 Procter & Gamble Mid-chain branced surfactants
US5994500A (en) 1996-07-19 1999-11-30 1149336 Ontario Inc. Antagonists of intestinotrophic GLP-2 peptides
US6077949A (en) 1996-12-13 2000-06-20 Allelix Biopharmaceuticals, Inc. Cloned glucagon-like peptide 2 receptors
BR9808804A (pt) 1997-05-16 2001-09-18 Ontario Inc Processos para tratar um indivìduo para melhorar o funcionamento do trato gastrointestinal superior incluindo o esÈfago e o estÈmago, para tratar um indivìduo para proliferar o tecido do trato gastrointestinal superior, para identificar peptìdeos utilizável para tratar condições inflamatórias, para identificar peptìdeos, utilizável para evitar ou melhorar as condições inflamatórias, utilizável para identificar peptìdeos capazes de proliferar tecido do trato gastrointestinal superior, para tratar profilaticamente um indivìduo, para melhorar o crescimento do tecido do trato gastrointestinal superior em um mamìfero, e para tratar um indivìduo para melhorar o funcionamento do trato gastrointestinal superior, kit, processos para promover o crescimento de tecido do trato gastrointestinal superior ou células, para tratar um paciente para restaurar o trato gastrointestinal superior, para determinar a atividade de um hormÈnio quando usado em combinação com glp-2, para tratar um indivìduo tendo úlceras peptìdicas
AU2712899A (en) 1998-02-27 1999-09-15 Novo Nordisk A/S Glp-2 derivatives with helix-content exceeding 25 percent, forming partially structured micellar-like aggregates
GB9930882D0 (en) 1999-12-30 2000-02-23 Nps Allelix Corp GLP-2 formulations
PT1360202E (pt) 2001-02-16 2008-09-01 Conjuchem Biotechnologies Inc Peptídeo do tipo glucagon 2 (glp-2) de longa duração para o tratamento de doenças e distúrbios gastrointestinais
WO2004035624A2 (en) 2002-10-14 2004-04-29 Novo Nordisk A/S Glucagon - like peptide - 2 variants
EP1608680A2 (en) 2003-03-24 2005-12-28 Novo Nordisk A/S Glp-2 derivatives
DK1809318T3 (da) * 2004-11-01 2013-09-08 Nps Pharma Inc Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet

Also Published As

Publication number Publication date
US9974836B2 (en) 2018-05-22
US20170020982A1 (en) 2017-01-26
US20190275113A1 (en) 2019-09-12
US20190269760A1 (en) 2019-09-05
US9968658B2 (en) 2018-05-15
US20170020988A1 (en) 2017-01-26
US9968656B2 (en) 2018-05-15
US20210213106A1 (en) 2021-07-15
WO2006050244A2 (en) 2006-05-11
US20210213105A1 (en) 2021-07-15
EP1809318B1 (en) 2013-06-12
US20170020977A1 (en) 2017-01-26
US20170020983A1 (en) 2017-01-26
US20170020979A1 (en) 2017-01-26
US9981015B2 (en) 2018-05-29
US20170020986A1 (en) 2017-01-26
US20200390862A1 (en) 2020-12-17
US20200206316A1 (en) 2020-07-02
WO2006050244A3 (en) 2006-09-08
US9974838B2 (en) 2018-05-22
US9555079B1 (en) 2017-01-31
JP5197012B2 (ja) 2013-05-15
US20170020974A1 (en) 2017-01-26
US9981016B2 (en) 2018-05-29
US20170020967A1 (en) 2017-01-26
US20200016241A1 (en) 2020-01-16
US9974835B2 (en) 2018-05-22
US20200147182A1 (en) 2020-05-14
US20170020973A1 (en) 2017-01-26
US20170020970A1 (en) 2017-01-26
US20170020984A1 (en) 2017-01-26
US20200376085A1 (en) 2020-12-03
US20200164041A1 (en) 2020-05-28
US20170028028A1 (en) 2017-02-02
US20200129594A1 (en) 2020-04-30
US9060992B2 (en) 2015-06-23
US20200164040A1 (en) 2020-05-28
US20170020975A1 (en) 2017-01-26
US20170020987A1 (en) 2017-01-26
US9968655B2 (en) 2018-05-15
US20190275112A1 (en) 2019-09-12
US9539310B1 (en) 2017-01-10
US20210015904A1 (en) 2021-01-21
US20200147181A1 (en) 2020-05-14
US9987334B2 (en) 2018-06-05
US20200405818A1 (en) 2020-12-31
US20170020966A1 (en) 2017-01-26
US20170020965A1 (en) 2017-01-26
US20170020978A1 (en) 2017-01-26
US20150290296A1 (en) 2015-10-15
US20170028029A1 (en) 2017-02-02
US20170020968A1 (en) 2017-01-26
US20190351027A1 (en) 2019-11-21
US20210000923A1 (en) 2021-01-07
US20200376084A1 (en) 2020-12-03
US20190298806A1 (en) 2019-10-03
US9545435B1 (en) 2017-01-17
US20170028024A1 (en) 2017-02-02
US20210077586A1 (en) 2021-03-18
US20190275111A1 (en) 2019-09-12
HK1107026A1 (en) 2008-03-28
US20200129593A1 (en) 2020-04-30
US9981014B2 (en) 2018-05-29
US20170020972A1 (en) 2017-01-26
US20170020980A1 (en) 2017-01-26
CA2585482C (en) 2018-01-02
US20170020989A1 (en) 2017-01-26
US20200397866A1 (en) 2020-12-24
US20170020985A1 (en) 2017-01-26
US20170020971A1 (en) 2017-01-26
US20210015903A1 (en) 2021-01-21
US20210038695A1 (en) 2021-02-11
US20180264087A1 (en) 2018-09-20
US9974837B2 (en) 2018-05-22
US9993528B2 (en) 2018-06-12
US7847061B2 (en) 2010-12-07
US20170020981A1 (en) 2017-01-26
US9968657B2 (en) 2018-05-15
US20170020976A1 (en) 2017-01-26
US20060135424A1 (en) 2006-06-22
US20110172152A1 (en) 2011-07-14
US9999656B2 (en) 2018-06-19
ES2427150T3 (es) 2013-10-29
US20190381146A1 (en) 2019-12-19
JP2008518941A (ja) 2008-06-05
EP1809318A2 (en) 2007-07-25
US9987335B2 (en) 2018-06-05
US20170028027A1 (en) 2017-02-02
US20200164043A1 (en) 2020-05-28
US9592274B2 (en) 2017-03-14
US20190307852A1 (en) 2019-10-10
US20190262427A1 (en) 2019-08-29
US20200138910A1 (en) 2020-05-07
US9572867B2 (en) 2017-02-21
US20170020969A1 (en) 2017-01-26
US20190262428A1 (en) 2019-08-29
US20170028026A1 (en) 2017-02-02
US9545434B2 (en) 2017-01-17
US9592273B2 (en) 2017-03-14
US20190298807A1 (en) 2019-10-03
US20170028030A1 (en) 2017-02-02
US20170028025A1 (en) 2017-02-02
US20210236603A1 (en) 2021-08-05
CA2585482A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
DK1809318T3 (da) Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet
DK1755616T3 (da) Behandling af ekssudativ retinopati med mineralkortikoider
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
NO20066007L (no) Rullestol med mekanisk arm
DK1890684T3 (da) Behandling af søvn/vågenhedsforstyrrelser
DK1981506T6 (da) Langtidsbehandling af hiv-infektion med tcm278
DK1727567T3 (da) Aptamer-terapeutiske midler nyttige i behandling af komplementrelaterede forstyrrelser
EE200500033A (et) Latentse tuberkuloosi ravi
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
DK1776136T3 (da) Behandling af tilstande, der involverer demyelinisering
DK2114447T3 (da) Forebyggelse og behandling af subkliniks pcvd
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK2125004T3 (da) Synergistisk terapeutisk anvendelse af prothrombinkompleks koncentrater med fviii koncentrater
DK1938528T3 (da) Provision af qos-behandling baseret på flere anmodninger
CY2200156T2 (el) Επεξεργασια λυματων
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
DK2191831T3 (da) Modificering af pirfenidon-behandling for patienter med atypisk leverfunktion
DK1945277T3 (da) Opretholdelse af desinfektion af medicinsk udstyr
DK1965787T3 (da) Behandling af xerostomi med en svovlindeholdende antioxidant
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DK1849488T3 (da) Kirurgisk kassette med eftergivende klemmezone
DK1848415T3 (da) Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
DK1962869T3 (da) Behandling af luftvejssygdomme
DK2007769T3 (da) Dimerer af artemisininderivater, fremstilling deraf og terapeutisk anvendelse deraf